MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$157,658,000
Foreign currency
translation gain (loss)
$14,000
Realized gain on
investments, net
$13,750
Interest income, net
$7,035,000
Unrealized gain (loss) on
securities
-$10,000
Net loss
-$157,662,000
Total other income,
net
$7,076,000
Loss from operations
-$164,738,000
Total operating
expenses
$164,738,000
General and
administrative
$11,280,000
Research and development
$153,458,000
Back
Back
Income Statement
source: myfinsight.com
viking_9_15_logo-svg
Viking Therapeutics, Inc. (VKTX)
viking_9_15_logo-svg
Viking Therapeutics, Inc. (VKTX)